These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 3874945)

  • 1. Inherited absence of OKT4 lymphocyte antigen in a chronically transfused patient with homozygous sickle cell disease.
    Gill JC; Maples J; Nikaein A; Kirchner P; Lockhart D; Snyder AJ; Montgomery RR; Casper JT
    J Pediatr; 1985 Aug; 107(2):251-3. PubMed ID: 3874945
    [No Abstract]   [Full Text] [Related]  

  • 2. Lymphocyte phenotype and function in chronically transfused children with sickle cell disease.
    Wang W; Herrod H; Presbury G; Wilimas J
    Am J Hematol; 1985 Sep; 20(1):31-40. PubMed ID: 4025320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunological studies in sickle cell disease. I. Analysis of circulating T-lymphocyte subpopulations.
    Ades EW; Hinson A; Morgan SK
    Clin Immunol Immunopathol; 1980 Nov; 17(3):459-62. PubMed ID: 6448723
    [No Abstract]   [Full Text] [Related]  

  • 4. Cellular immune functions in sickle cell anemia.
    Ogunye OO; Uy CG; Sheagren JN; Strober W
    Niger Med J; 1979 Jan; 9(1):33-8. PubMed ID: 313641
    [No Abstract]   [Full Text] [Related]  

  • 5. T lymphocyte study in sickle cell anaemia by means of rosetting techniques.
    Hernández P; Cruz C
    Acta Haematol; 1985; 73(1):59-60. PubMed ID: 3923772
    [No Abstract]   [Full Text] [Related]  

  • 6. Cell-mediated immunity in patients with sickle cell anaemia.
    Sanhadji K; Chout R; Gessain A; Sasco AJ; Yoyo M; Mezard F; de The G; Touraine JL
    Thymus; 1988-1989; 12(4):203-13. PubMed ID: 3267159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell cycle distribution defect in PHA-stimulated T lymphocytes of sickle cell disease patients.
    Abdallah JM; Kukuruga M; Nakeff A; Prasad AS
    Am J Hematol; 1988 Aug; 28(4):279-81. PubMed ID: 3261939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B-cell changes occur in patients with sickle cell anemia.
    Venkataraman M; Westerman MP
    Am J Clin Pathol; 1985 Aug; 84(2):153-8. PubMed ID: 3895887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiphospholipid antibodies in homozygous sickle cell disease.
    De Ceulaer K; Khamashta MA; Harris EN; Serjeant GR; Hughes GR
    Ann Rheum Dis; 1992 May; 51(5):671-2. PubMed ID: 1616337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. -318C/T polymorphism of the CTLA-4 gene is an independent risk factor for RBC alloimmunization among sickle cell disease patients.
    Oliveira VB; Dezan MR; Gomes FCA; Menosi Gualandro SF; Krieger JE; Pereira AC; Marsiglia JD; Levi JE; Rocha V; Mendrone-Junior A; Sabino EC; Dinardo CL
    Int J Immunogenet; 2017 Oct; 44(5):219-224. PubMed ID: 28815969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mononuclear cells in sickle cell disease: subpopulations and in vitro response to mitogens.
    Hendriks J; De Ceulaer K; Williams E; Serjeant GR
    J Clin Lab Immunol; 1984 Mar; 13(3):129-32. PubMed ID: 6609238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T cell requirements for generation of helper factor(s) in man: analysis of the subsets involved.
    Reinherz EL; Kung PC; Breard JM; Goldstein G; Schlossman SF
    J Immunol; 1980 Apr; 124(4):1883-7. PubMed ID: 6965964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. rs660 polymorphism in Ro52 (SSA1; TRIM21) is a marker for age-dependent tolerance induction and efficiency of alloimmunization in sickle cell disease.
    Tatari-Calderone Z; Minniti CP; Kratovil T; Stojakovic M; Vollmer A; Barjaktarevic I; Zhang E; Hoang A; Luban NL; Vukmanovic S
    Mol Immunol; 2009 Nov; 47(1):64-70. PubMed ID: 19201475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Further dissection of the functional heterogeneity within the OKT4+ and OKT8+ human T cell subsets.
    Thomas Y; Rogozinski L; Rothman P; Rabbani LE; Andrews S; Irigoyen OH; Chess L
    J Clin Immunol; 1982 Jul; 2(3 Suppl):8S-14S. PubMed ID: 6215426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphocyte subpopulations in homozygous sickle cell anaemia.
    Adedeji MO
    Acta Haematol; 1985; 74(1):10-3. PubMed ID: 3934900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Red blood cell transfusions are associated with HLA class I but not H-Y alloantibodies in children with sickle cell disease.
    Nickel RS; Hendrickson JE; Yee MM; Bray RA; Gebel HM; Kean LS; Miklos DB; Horan JT
    Br J Haematol; 2015 Jul; 170(2):247-56. PubMed ID: 25891976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Red cell exchange does not appear to increase the rate of allo- and auto-immunization in chronically transfused children with sickle cell disease.
    Venkateswaran L; Teruya J; Bustillos C; Mahoney D; Mueller BU
    Pediatr Blood Cancer; 2011 Aug; 57(2):294-6. PubMed ID: 21298771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA type and risk of alloimmunization in sickle cell disease.
    Hoppe C; Klitz W; Vichinsky E; Styles L
    Am J Hematol; 2009 Jul; 84(7):462-4. PubMed ID: 19484735
    [No Abstract]   [Full Text] [Related]  

  • 19. Nephropathy associated with sickle cell anemia: an autologous immune complex nephritis. II. Clinicopathologic study of seven patients.
    Pardo V; Strauss J; Kramer H; Ozawa T; McIntosh RM
    Am J Med; 1975 Nov; 59(5):650-9. PubMed ID: 128292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Possible involvement of the OKT4 molecule in T-cell recognition of class II HLA antigens.
    Biddison WE; Shaw S
    Diagn Immunol; 1983; 1(3):112-5. PubMed ID: 6209053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.